Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale

Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale

Le rein est particulièrement exposé à de nombreux composés chimiques dont des médicaments, potentiellement néphrotoxiques. Parmi-eux, le Tacrolimus, un anti-calcineurine largement utilisé en transplantation rénale, est associé à l’apparition plus ou moins rapide de lésions histologique de toxicité c...

Full description

Bibliographic Details
Main Author:	Glowacki, François
Other Authors:	Lille 2
Language:	fr
Published:	2012
Subjects:	CYP3A5 ABCB1 Tacrolimus Renal function
Online Access:	http://www.theses.fr/2012LIL2S003/document

Similar Items

Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale
by: Glowacki, François-Xavier
Published: (2012)

Déterminants moléculaires de la néphrotoxicité induite par le tacrolimus après transplantation rénale
by: Van Der Hauwaert, Cynthia
Published: (2014)

Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in the long-term period after renal transplantation
by: Stefanović Nikola Z., et al.
Published: (2015-01-01)

The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
by: Emaad Abdel-Kahaar, et al.
Published: (2019-09-01)

Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients
by: Marwa Helal, et al.
Published: (2017-07-01)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
by: Hideaki Kagaya, et al.
Published: (2018-03-01)

Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
by: Daniel A. Brazeau, et al.
Published: (2020-08-01)

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients
by: Yilei Yang, et al.
Published: (2021-07-01)

Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation
by: Takenori Niioka, et al.
Published: (2015-01-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Efficacy and outcomes of CYP3A5 genotype-based tacrolimus dosing compared to conventional body weight-based dosing in living donor kidney transplant recipients
by: Edwin Fernando, M., et al.
Published: (2022)

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients
by: Jing Zhu, et al.
Published: (2020-01-01)

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01)

Clinical utility of ABCB1 single nucleotide polymorphism on tacrolimus dose requirements in Egyptian liver transplant patients
by: Azza Abd El-rahman Saab, et al.
Published: (2021-08-01)

Interactions between Tacrolimus and Metronidazole in a renal transplant patient
by: Catic-Djordjevic Aleksandra, et al.
Published: (2012-10-01)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020-07-01)

The distribution of genetic polymorphism of CYP3A5, CYP3A4 and ABCB1 in patients subjected to renal transplantation
by: Vavić Neven, et al.
Published: (2016-01-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Tacrolimus as a rare cause of pericardial effusion in a renal transplant recipient
by: Rohini Prashar, et al.
Published: (2017-01-01)

Clinical and Pharmacogenomic Evaluation of Tacrolimus Formulations
by: Tremblay, Simon
Published: (2018)

Pharmacogénétique des immunomodulateurs chez les receveurs de greffe rénale
by: Roy, Jean-Nicholas
Published: (2016)

Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function
by: Yuan Liu, et al.
Published: (2019-05-01)

A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients
by: Krishna Asuri, et al.
Published: (2020-01-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Influence of CYP3A5 and ABCB1 polymorphism on tacrolimus drug dosing in South Indian renal allograft recipients
by: M Edwin Fernando, et al.
Published: (2019-01-01)

SIGNIFICANCE OF CYP3A5 GENE POLYMORPHISM IN SERBIAN RENAL TRANSPLANT PATIENTS
by: Nikola Stefanovi ć, et al.
Published: (2013-03-01)

Microangiopatía trombótica en el trasplante renal, el tacrolimus como causante
by: Juan E. Rodríguez-Mori, et al.
Published: (2020-12-01)

Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
by: Effrosyni Mendrinou, et al.
Published: (2020-08-01)

Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome
by: Min Li, et al.
Published: (2018-04-01)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

Drug-drug interactions of tacrolimus
by: Rančić Nemanja K., et al.
Published: (2015-01-01)

Comparison of patient and graft survival in tacrolimus versus cyclosporine-based immunosuppressive regimes in renal transplant recipients – Single-center experience from South India
by: Kiran Chandra Patro, et al.
Published: (2018-01-01)

Massive pleural effusion in a renal transplant recipient on tacrolimus
by: L S Nayagam, et al.
Published: (2014-01-01)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
by: Zhang C, et al.
Published: (2020-04-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
by: Keiichi Haga, et al.
Published: (2020-06-01)

Unilateral common peroneal nerve palsy following renal transplantation: A case report of tacrolimus neurotoxicity
by: A Jain, et al.
Published: (2011-01-01)

Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient
by: Prakash Khetan, et al.
Published: (2019-01-01)

HEMOFILTRATION AND COUPLED PLASMA FILTRATION ADSORPTION IMPACT ON TACROLIMUS BLOOD CONCENTRATION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)